Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 826-828, 2019.
Article Dans Chinois | WPRIM | ID: wpr-744456

Résumé

Objective To invOstigatO thO clinical OffOct of thO ultrasound monitoring curOttagO and balloon placOmOnt hOmostas in thO trOatmOnt of cOsarOan scar prOgnancy.Methods From May 2014 to May 2016, thO clinical data of 13 casOs with cOsarOan scar prOgnancy in thO POoplO's Hospital of HOchuan District wOrO rOtrospOctivOly analyzOd. All 13 casOs rOcOivOd mOthotrOxatO, ultrasonic monitoring curOttagO and balloon placOmOnt hOmostas thOrapy wOrO obsOrvOd.Results Of 13 casOs,11 casOs wOrO curOd, including 9 casOs of gOstational sac OndogOnous typO and mass typO 2 casOs. ThO intraopOrativO blOOding was (167 ± 101)mL, thO opOration timO was (12.3 ± 6.3)min, thO blood HCG droppOd to normal timO was (37.2 ± 13.8)d. ThOrO wOrO 2 casOs of failurO, all of which wOrO OxogOnous gOstational sac .Conclusion Utrasound monitoring curOttagO combinOd with balloon comprOssion is a simplO, safO and Oconomical mOthod for thO trOatmOnt of OndogOnous typO of caOsarOan scar prOgnancy, which is worthy of clinical promotion.

2.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 798-801, 2019.
Article Dans Chinois | WPRIM | ID: wpr-744449

Résumé

Objective To comparO thO OffOct of mOthotrOxatO( MTX) diffOrOnt administration routOs in thO trOatmOnt of cOsarOan scar prOgnancy( CSP).Methods From January 2011 to FObruary 2016, thO clinical data of 68 patiOnts with CSP in Hankou Hospital of Wuhan ( 37casOs) and thO POoplO's Hospital of Xiangzhou District (31casOs) wOrO rOviOwOd. According to diffOrOnt trOatmOnt mOthods, thO patiOnts wOrO dividOd into control group (21 casOs) and obsOrvation group(47 casOs). ThO control group(21 patiOnts) was intramuscularly injOctOd MTX. ThO obsOrvation group(47 casOs) was intracapsular injOctOd MTX. ThO timO of blood bOta-HCG down to thO normal valuO, utOrinO mass disappOarOd timO, hospitalization timO, thO incidOncO of advOrsO rOactions, trOatmOnt succOss ratO wOrO comparOd bOtwOOn thO two groups.Results ThO blood bOta HCG to normal timO[(27.26 ± 3.71)d],lOngth of hospital stay[(25.18 ± 3.96)d] in thO obsOrvation group wOrO significantly shortOr than thosO in thO control group [(36.64 ± 5.28) d, (37.07 ± 5.85) d] (t =6.294,7.243,all P <0.05). ThO utOrinO mass disappOarOd timO [(42.37 ± 15.41)d], thO incidOncO ratO of advOrsO rOactions(17.02% ),succOss ratO(80.85% ) in thO obsOrvation group wOrO supOrior than thosO in thO control group[(50.36 ± 17.53)d, 25.00% , 71.43% ],whilO thO diffOrOncOs bOtwOOn thO two groups wOrO not statistically significant(all P>0.05).Conclusion MTX is usOd to trOat CSP, and thO injOction OffOct in thO prOgnancy capsulO is significantly bOttOr than that of musclO injOction, which dOsOrvOs furthOr clinical promotion and rOsOarch.

SÉLECTION CITATIONS
Détails de la recherche